NEW YORK (TheStreet) -- Shares of Affymetrix  (AFFX) fell 6.44% to $10.90 in late morning trading Wednesday after Robert W. Baird downgraded the stock to "neutral" from "outperform" and maintained its $11 price target.

Affymetrix, which manufactures DNA microarrays, holds a 52-week low of $6.25 and a 52-week high of $11.89. The stock hit an intraday low of $10.75 and an intraday high of $11.42.

More than 2 million shares had changed hands as of 11:38 a.m., compared to the daily average volume of 836,163.

Affymetrix CFO Gavin Wood sold 10,200 shares of the company's stock at an average price of $10.77 for a total price of $109,854 in a transaction on Monday, January 12th. The sale was disclosed in a filing with the SEC.

Exclusive Report: Jim Cramer’s Best Stocks for 2015

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

AFFX Chart AFFX data by YCharts

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.